Treatment Innovations

GSK Fortifies Hepatitis B Strategy with Strategic Sino Biopharmaceutical Partnership gsk-fortifies-hepatitis-b-strategy-with-strategic-sino-biopharmaceutical-partnership

GSK Fortifies Hepatitis B Strategy with Strategic Sino Biopharmaceutical Partnership

Ali Ikhwan May 11, 2026

By Delilah Alvarado | May 11, 2026 In a move signaling a deepening commitment to the Chinese...

The Frontier of Hope: Navigating the High-Stakes Logistics of Cell and Gene Therapy the-frontier-of-hope-navigating-the-high-stakes-logistics-of-cell-and-gene-therapy

The Frontier of Hope: Navigating the High-Stakes Logistics of Cell and Gene Therapy

Siti Muinah May 11, 2026

The advent of personalized medicine has ushered in a transformative era for global healthcare. At the heart...

Advancing Orthopaedic Precision: Xtant Medical Launches Trivium Shaped Allograft to Streamline Surgical Workflows advancing-orthopaedic-precision-xtant-medical-launches-trivium-shaped-allograft-to-streamline-surgical-workflows

Advancing Orthopaedic Precision: Xtant Medical Launches Trivium Shaped Allograft to Streamline Surgical Workflows

Nana May 11, 2026

In a move set to redefine efficiency in the operating theatre, US-based orthobiologics leader Xtant Medical Holdings...

The "Vibe-Coded" Unicorn Under Fire: Scrutinizing Medvi’s Risky QUAD Cocktail the-vibe-coded-unicorn-under-fire-scrutinizing-medvis-risky-quad-cocktail

The "Vibe-Coded" Unicorn Under Fire: Scrutinizing Medvi’s Risky QUAD Cocktail

Nana Wu May 11, 2026

The rapid ascent of Medvi, a digital health startup recently lauded by The New York Times as...

Roche Announces Strategic $1.05bn Acquisition of PathAI to Transform Digital Pathology roche-announces-strategic-1-05bn-acquisition-of-pathai-to-transform-digital-pathology

Roche Announces Strategic $1.05bn Acquisition of PathAI to Transform Digital Pathology

Asro May 11, 2026

In a move set to redefine the landscape of precision medicine, global healthcare giant Roche has entered...

Bridging the Gap: Sai Life Sciences Cultivates the Next Generation of Biotech Innovation at Pitch Day 2026 bridging-the-gap-sai-life-sciences-cultivates-the-next-generation-of-biotech-innovation-at-pitch-day-2026

Bridging the Gap: Sai Life Sciences Cultivates the Next Generation of Biotech Innovation at Pitch Day 2026

Laily UPN May 10, 2026

In the high-stakes world of drug discovery, the transition from a laboratory concept to a clinical candidate...

Revolutionizing Oncology: ArteraAI Secures FDA Clearance for Landmark Breast Cancer Risk Assessment Tool revolutionizing-oncology-arteraai-secures-fda-clearance-for-landmark-breast-cancer-risk-assessment-tool

Revolutionizing Oncology: ArteraAI Secures FDA Clearance for Landmark Breast Cancer Risk Assessment Tool

Ali Ikhwan May 10, 2026

In a significant leap forward for precision oncology, Artera has announced that its innovative ArteraAI Breast software...

The New Pharma Hegemony: Beyond Keytruda and the Rise of the GLP-1 Era the-new-pharma-hegemony-beyond-keytruda-and-the-rise-of-the-glp-1-era

The New Pharma Hegemony: Beyond Keytruda and the Rise of the GLP-1 Era

Neng Nana May 10, 2026

The pharmaceutical industry has reached a historic inflection point. For years, the oncology juggernaut Keytruda (pembrolizumab) has...

The AI-Native Revolution: Inside the $2.75 Billion Insilico-Lilly Collaboration the-ai-native-revolution-inside-the-2-75-billion-insilico-lilly-collaboration

The AI-Native Revolution: Inside the $2.75 Billion Insilico-Lilly Collaboration

Asep Darmawan May 10, 2026

In a landmark deal that underscores the seismic shift occurring within the pharmaceutical industry, Insilico Medicine has...

Becton Dickinson Rebounds: FY26 Profit Guidance Lifted Following Strong Second-Quarter Performance becton-dickinson-rebounds-fy26-profit-guidance-lifted-following-strong-second-quarter-performance

Becton Dickinson Rebounds: FY26 Profit Guidance Lifted Following Strong Second-Quarter Performance

Raul Delapena Setiawan May 10, 2026

In a significant strategic reversal, Becton Dickinson and Company (BD) has announced an upward revision to its...

GSK Fortifies Hepatitis B Strategy with Strategic Sino Biopharmaceutical Partnership

The Frontier of Hope: Navigating the High-Stakes Logistics of Cell and Gene Therapy

Advancing Orthopaedic Precision: Xtant Medical Launches Trivium Shaped Allograft to Streamline Surgical Workflows

The "Vibe-Coded" Unicorn Under Fire: Scrutinizing Medvi’s Risky QUAD Cocktail

Roche Announces Strategic $1.05bn Acquisition of PathAI to Transform Digital Pathology

Bridging the Gap: Sai Life Sciences Cultivates the Next Generation of Biotech Innovation at Pitch Day 2026

Revolutionizing Oncology: ArteraAI Secures FDA Clearance for Landmark Breast Cancer Risk Assessment Tool

The New Pharma Hegemony: Beyond Keytruda and the Rise of the GLP-1 Era

The AI-Native Revolution: Inside the $2.75 Billion Insilico-Lilly Collaboration

Becton Dickinson Rebounds: FY26 Profit Guidance Lifted Following Strong Second-Quarter Performance

You may have missed

Breakthrough in Breast Cancer: Penn Scientists Uncover Path to Eradicate Dormant Cells, Prevent Recurrence

MHRA Embraces Contextual Safety Assessments for Clinical Trial Applications, Bolstering UK’s Regulatory Agility

A Beacon of Hope: Shelly’s Journey Through Breast Cancer, Illuminated by Patient Navigation

Bridging the Gap in Women’s Health: CAKES Body Extends Landmark Partnership with BCRF to Fund Research for Younger Women